The next six months will be crucial in determining how the West and China cooperate on regulating the fast-growing technology.
U.S. Secretary of Commerce Gina Raimondo (left) and the U.K's Secretary of State for Science, Innovation and Technology, Michelle Donelan (center), listen as Wu Zhaohui, Vice Minister of Science and Technology for China, speaks during the AI Safety Summit at Bletchley Park in Milton Keynes, England, November 1, 2023. Credit: Press Association via AP Images
Much has been written over the past six months about how Beijing is grappling with the regulation of generative artificial intelligence (AI), in the process corralling large language models (LLMs) and the platforms that use them via chatbots. In this endeavor, Beijing has arguably been out in front of other governments, particularly the U.S., by building a set of tools rather than trying to develop sweeping regulation such as the European Union’s AI Act.
Chinese firms are clearly amon
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
At the height of the pandemic, Chinese vaccine maker Sinovac was a hero and one of the country’s most promising companies. But its success masked a protracted dispute between rival investors and management for control of the cash-rich company. The Wire China investigates what went wrong.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
